BioNTech: Better wait and see!

Good sentiment at BioNTech

The investor sentiment at Biontech in the discussion forums and opinion columns of social media is particularly positive overall. This is reflected in the statements and opinions of the past two weeks, which we have evaluated for you to gain another valuation factor for the stock. This showed that neither positive nor negative topics were the focus of discussions in the past one to two days, giving the stock an overall Buy rating. Thus, according to our assessment, a “Buy” is calculated on the point of investor sentiment overall.

RSI signal worries investors

The Relative Strength Index, abbreviated as RSI, indexes the movements of stock prices within 7 days by relating the upward movements to the number of movements. The standard range is from 0 to 100, The RSI of Biontech is 81.09, which means that the situation is considered overbought. This results in a rating as “Sell”. The RSI25 extends the calculation period to 25 days. The RSI for Biontech is 38.01. This is considered an indicator of a situation that is neither overbought nor oversold, which is assigned a “Hold” rating. Overall, we therefore assign a “Sell” rating for this category.

Technical analysis of the price performance

On the basis of the moving average price, Biontech is currently a “Hold”. This is because the GD200 of the value runs at the level of EUR 145.78, which means that the price of the share (EUR 149.7) is +2.69 percent above this trend signal. This corresponds to a “Hold” rating. Based on the past 50 days, this results in a moving average price (GD50) of EUR 142.98. This in turn corresponds to a deviation of +4.7 percent from the perspective of the share price itself. This means that the share is a “hold” value over this period. Overall, this corresponds to a “Hold” rating.